Delivery Order SPE2DX22D0079-SPE2D826FAAK9
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,100.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20,927.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $8,154.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with completion scheduled for October 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is being performed at the vendor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,123.51 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency's Medical Supply Chain awarded a $805,215.89 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitive, firm fixed-price contract was issued without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,583 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 20, 2025, with completion expected by October 21, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,045.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 27, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency's Medical Supply Chain awarded a $24,907.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,336.48 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FAAK9Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $2,796.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with completion expected by November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order was placed to the vendor's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. As a critical vendor for military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies through its DLA contracts, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet procurement requirements through competitive award processes, with delivery orders ranging from small transactions to substantial orders. This particular delivery order falls within AmerisourceBergen's established role as a pharmaceutical prime vendor supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/3/25 |